Translational Autoimmunity: Advances in Autoimmune Rheumatic Diseases, Volume Six addresses autoimmune diseases classified under the category of rheumatic diseases. Rheumatic diseases are heterogeneous groups of disorders in which inflammation affects not only joints, but also tendons, ligaments and bones. This updated release focuses on immunopathogenesis and clinical and laboratory details of rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, osteoarthritis and Sjogren’s syndrome, and will be of interest to researchers, students and clinicians interested in autoimmune diseases, especially rheumatic diseases.
From an introduction to rheumatic diseases to diagnostic laboratory tests, and from the microbiota-immunity to cell-based therapies, the bench to bedside approach to rheumatic diseases is the main subject of discussion in this comprehensive resource.
1. Chapter 1 : Introduction on autoimmune rheumatic diseases - p. Page xix 2. Chapter 2 : Bone Health in autoimmune inflammatory rheumatic diseases - p. Page 6 3. Chapter 3 : Rheumatic diseases: From bench to bedside - p. Page 21 4. Chapter 4 : Rheumatic fever: From pathogenesis to vaccine perspectives - p. Page 41 5. Chapter 5 : Changes in future rheumatoid arthritis treatment in the light of Epstein-Barr virus infection - p. Page 58 6. Chapter 6 : Rheumatic diseases: The microbiota-immunity axis in development and treatment - p. Page 74 7. Chapter 7 : The diagnostic laboratory tests in rheumatic diseases - p. Page 101 8. Chapter 8 : Autoantibody profiling in autoimmune rheumatic diseases: How research may translate into clinical practice - p. Page 138 9. Chapter 9 : Air pollution and rheumatoid arthritis: Current knowledge and state of the art - p. Page 164 10. Chapter 10 : Advanced therapies in rheumatoid arthritis - p. Page 179 11. Chapter 11 : A tolerogenic dendritic cell–based therapy targeting heat shock protein–specific regulatory T cells in rheumatoid arthritis - p. Page 200 12. Chapter 12 : T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis - p. Page 217 13. Chapter 13 : Biomaterials as tools for re-balancing skewed immunity in rheumatoid arthritis - p. Page 228 14. Chapter 14 : Immunopathogenesis of systemic lupus erythematosus - p. Page 257 15. Chapter 15 : Challenges in systemic lupus erythematosus: From bench to bedside - p. Page 283 16. Chapter 16 : Therapeutic potential of the current options in treating systemic lupus erythematosus: Challenges and prospective - p. Page 324 17. Chapter 17 : The pathology and potential clinical applicability of interfering T cells in systemic lupus erythematosus - p. Page 343 18. Chapter 18 : Rheumatic chorea - p. Page 364 19. Chapter 19 : Evaluation and surgical management of the rheumatoid foot and ankle - p. Page 383 20. Chapter 20 : Immunopathogenesis and treatment of scleroderma - p. Page 422 21. Chapter 21 : Skin manifestations and autoimmune disturbances in dermatomyositis - p. Page 434 22. Chapter 22 : T cells in the pathogenesis of systemic sclerosis - p. Page 444 23. Chapter 23 : Etiopathogenesis of Behçet’s syndrome: The role of infectious, genetic, and immunological environmental factors - p. Page 464 24. Chapter 24 : Interleukin-1 family in Behçet’s disease: Inflammatory and antiinflammatory mediators - p. Page 481 25. Chapter 25 : Salivary gland regeneration and repair in Sjögren’s syndrome - p. Page 501 26. Chapter 26 : Regulation of bone and joint inflammation by type 2 innate lymphoid cells - p. Page 526 27. Chapter 27 : Arboviruses (Alphavirus) related to autoimmune rheumatic diseases: Triggers and possible therapeutic interventions - p. Page 539 28. Chapter 28 : Rheumatologic manifestations of autoinflammatory diseases - p. Page 556 29. Index - p. Page 579
Translational Autoimmunity: Advances in Autoimmune Rheumatic Diseases, Volume Six addresses autoimmune diseases classified under the category of rheumatic diseases. Rheumatic diseases are heterogeneous groups of disorders in which inflammation affects not only joints, but also tendons, ligaments and bones. This updated release focuses on immunopathogenesis and clinical and laboratory details of rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, osteoarthritis and Sjogren’s syndrome, and will be of interest to researchers, students and clinicians interested in autoimmune diseases, especially rheumatic diseases.
From an introduction to rheumatic diseases to diagnostic laboratory tests, and from the microbiota-immunity to cell-based therapies, the bench to bedside approach to rheumatic diseases is the main subject of discussion in this comprehensive resource.
1. Chapter 1 : Introduction on autoimmune rheumatic diseases - p. Page xix 2. Chapter 2 : Bone Health in autoimmune inflammatory rheumatic diseases - p. Page 6 3. Chapter 3 : Rheumatic diseases: From bench to bedside - p. Page 21 4. Chapter 4 : Rheumatic fever: From pathogenesis to vaccine perspectives - p. Page 41 5. Chapter 5 : Changes in future rheumatoid arthritis treatment in the light of Epstein-Barr virus infection - p. Page 58 6. Chapter 6 : Rheumatic diseases: The microbiota-immunity axis in development and treatment - p. Page 74 7. Chapter 7 : The diagnostic laboratory tests in rheumatic diseases - p. Page 101 8. Chapter 8 : Autoantibody profiling in autoimmune rheumatic diseases: How research may translate into clinical practice - p. Page 138 9. Chapter 9 : Air pollution and rheumatoid arthritis: Current knowledge and state of the art - p. Page 164 10. Chapter 10 : Advanced therapies in rheumatoid arthritis - p. Page 179 11. Chapter 11 : A tolerogenic dendritic cell–based therapy targeting heat shock protein–specific regulatory T cells in rheumatoid arthritis - p. Page 200 12. Chapter 12 : T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis - p. Page 217 13. Chapter 13 : Biomaterials as tools for re-balancing skewed immunity in rheumatoid arthritis - p. Page 228 14. Chapter 14 : Immunopathogenesis of systemic lupus erythematosus - p. Page 257 15. Chapter 15 : Challenges in systemic lupus erythematosus: From bench to bedside - p. Page 283 16. Chapter 16 : Therapeutic potential of the current options in treating systemic lupus erythematosus: Challenges and prospective - p. Page 324 17. Chapter 17 : The pathology and potential clinical applicability of interfering T cells in systemic lupus erythematosus - p. Page 343 18. Chapter 18 : Rheumatic chorea - p. Page 364 19. Chapter 19 : Evaluation and surgical management of the rheumatoid foot and ankle - p. Page 383 20. Chapter 20 : Immunopathogenesis and treatment of scleroderma - p. Page 422 21. Chapter 21 : Skin manifestations and autoimmune disturbances in dermatomyositis - p. Page 434 22. Chapter 22 : T cells in the pathogenesis of systemic sclerosis - p. Page 444 23. Chapter 23 : Etiopathogenesis of Behçet’s syndrome: The role of infectious, genetic, and immunological environmental factors - p. Page 464 24. Chapter 24 : Interleukin-1 family in Behçet’s disease: Inflammatory and antiinflammatory mediators - p. Page 481 25. Chapter 25 : Salivary gland regeneration and repair in Sjögren’s syndrome - p. Page 501 26. Chapter 26 : Regulation of bone and joint inflammation by type 2 innate lymphoid cells - p. Page 526 27. Chapter 27 : Arboviruses (Alphavirus) related to autoimmune rheumatic diseases: Triggers and possible therapeutic interventions - p. Page 539 28. Chapter 28 : Rheumatologic manifestations of autoinflammatory diseases - p. Page 556 29. Index - p. Page 579
